HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph Jao Yiu Sung Selected Research

benzyloxycarbonylleucyl-leucyl-leucine aldehyde

2/2010Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells.
9/2009Repression of protein translation and mTOR signaling by proteasome inhibitor in colon cancer cells.
9/2008Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells.
6/2008Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph Jao Yiu Sung Research Topics

Disease

14Neoplasms (Cancer)
04/2021 - 06/2008
8Colonic Neoplasms (Colon Cancer)
09/2010 - 09/2008
6Stomach Neoplasms (Stomach Cancer)
06/2011 - 06/2008
5Carcinogenesis
06/2011 - 12/2008
4Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 07/2010
3Adenoma (Adenomas)
01/2020 - 06/2014
3Hemorrhage
08/2016 - 05/2007
2Peptic Ulcer (Peptic Ulcers)
08/2016 - 01/2009
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
09/2010 - 01/2009
2Adenocarcinoma
04/2010 - 06/2008
2Ulcer
01/2009 - 05/2007
1Rupture
08/2022
1Infections
08/2022
1Inflammation (Inflammations)
12/2021
1Hepatocellular Carcinoma (Hepatoma)
04/2021
1Osteoporosis
01/2021
1Dysbiosis
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2014
1Esophageal Achalasia (Megaesophagus)
01/2013
1Necrotizing Enterocolitis
08/2010
1Sepsis (Septicemia)
08/2010
1Hematologic Neoplasms (Hematological Malignancy)
07/2010
1Colitis
07/2010
1Gastric Outlet Obstruction
02/2010
1Arthritis (Polyarthritis)
05/2007
1Chronic Hepatitis (Chronic Active Hepatitis)
02/2006
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2006
1Hepatitis E
11/2003
1Thyrotoxicosis
11/2003
1Acute Liver Failure (Fulminant Hepatic Failure)
11/2003

Drug/Important Bio-Agent (IBA)

6Proteasome Endopeptidase Complex (Proteasome)IBA
07/2010 - 06/2008
5Proteasome InhibitorsIBA
07/2010 - 06/2008
4Biomarkers (Surrogate Marker)IBA
01/2017 - 08/2010
4benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
02/2010 - 06/2008
3Biological ProductsIBA
08/2022 - 04/2010
3Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
07/2010 - 06/2008
2Proteins (Proteins, Gene)FDA Link
12/2021 - 12/2008
2Pharmaceutical PreparationsIBA
01/2021 - 05/2007
2Proton Pump InhibitorsIBA
08/2016 - 05/2007
2Calcibiotic Root Canal SealerIBA
01/2016 - 06/2014
2MicroRNAs (MicroRNA)IBA
01/2016 - 06/2014
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2010 - 05/2007
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2010 - 12/2008
2ResveratrolIBA
07/2010 - 07/2010
2LigandsIBA
07/2010 - 01/2009
2NicotineFDA Link
06/2010 - 12/2008
2Celecoxib (Celebrex)FDA Link
05/2007 - 02/2006
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1LipidsIBA
12/2021
1Immune Checkpoint InhibitorsIBA
04/2021
1Fluorouracil (Carac)FDA LinkGeneric
04/2021
1Therapeutic UsesIBA
01/2021
1PrebioticsIBA
01/2021
116S Ribosomal RNAIBA
01/2020
1Omeprazole (Prilosec)FDA LinkGeneric
08/2016
1TOR Serine-Threonine KinasesIBA
06/2011
1Mechanistic Target of Rapamycin Complex 1IBA
06/2011
1Prostaglandins EIBA
09/2010
1Apolipoprotein C-II (ApoC2)IBA
08/2010
12,3',4,4',5'-pentamethoxystilbeneIBA
07/2010
1beta CateninIBA
07/2010
1AntioxidantsIBA
07/2010
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
06/2010
1Antimicrobial Cationic PeptidesIBA
04/2010
1Peptides (Polypeptides)IBA
04/2010
1CathelicidinsIBA
04/2010
1Messenger RNA (mRNA)IBA
04/2010
1Phosphotransferases (Kinase)IBA
02/2010
1bafilomycin A1IBA
05/2009
1Proton-Translocating ATPases (ATPase, H+)IBA
05/2009
1bafilomycin AIBA
05/2009
1Cyclooxygenase 1IBA
04/2009
1SC 560IBA
04/2009
1ErbB Receptors (EGF Receptor)IBA
01/2009
1beta Adrenergic ReceptorsIBA
12/2008
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2008
1SmokeIBA
12/2008
1Adrenergic Agents (Adrenergic Drugs)IBA
12/2008
14- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA
12/2008
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2007
1Esomeprazole (Nexium)FDA Link
05/2007
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2007
1Carbon Tetrachloride (Tetrachloromethane)IBA
02/2006
1Thioacetamide (Thioacetamid)IBA
02/2006
1Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2003

Therapy/Procedure

6Therapeutics
06/2011 - 06/2008
2Drug Therapy (Chemotherapy)
04/2021 - 07/2010
1Stents
08/2022
1Immunotherapy
04/2021
1Retreatment
08/2016
1Endoscopic Hemostasis
08/2016
1Myotomy
01/2013
1Bariatric Surgery
02/2010
1Vagotomy
01/2009
1Gastrectomy
01/2009
1Surgical Hemostasis
01/2009
1Chemoprevention
12/2008
1Pain Management
05/2007